Zydus Lifesciences disclosed a Code of Conduct violation under SEBI PIT Regulations 2015 to BSE and NSE on March 27, 2026.
General Manager (Marketing) Mr. Debtaru Upadhyay sold 10 equity shares on March 13, 2026 at ₹902.70/share, totalling ₹9,027, constituting a contra trade.
The company issued a warning letter; the DP admitted the trade was unintentional and incurred a loss of ₹170; no penalty amount was collected.